| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |